Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer

Mary Y. Wu,Scott T.C. Shepherd,Annika Fendler,Edward J. Carr,Lewis Au,Ruth Harvey,Giulia Dowgier, Agnieszka Hobbs, Lou S. Herman, Martina Ragno,Lorin Adams,Andreas M. Schmitt,Zayd Tippu,Benjamin Shum,Sheima Farag,Aljosja Rogiers,Nicola O’Reilly, Philip Bawumia, Callie Smith, Eleanor Carlyle

Cancer Cell（2023）

引用 2|浏览15

暂无评分

摘要

Wu et al. report that patients with hematologic malignancies have reduced immunity against SARS-CoV-2 Omicron subvariants and Sotrovimab retains neutralizing capacity against all tested Omicron subvariants.

查看译文

关键词

sotrovimab,current omicron subvariants,cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要